Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the metabolic syndrome market size evolved in recent years?
The market for metabolic syndrome has seen a robust growth in recent years. The market value, which is projected to be $84.03 billion in 2024, is anticipated to reach $90.60 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.8%. This growth in the historical phase can be traced back to factors such as the rise in sedentary work environments, expansion in the nutraceutical and functional food sector, growing consumer preference for natural products, a surge in clinical studies and trials, and the progression of digital healthcare.
What are the predictions for the metabolic syndrome market size in the coming years?
Over the coming years, the metabolic syndrome market size is anticipated to undergo robust expansion. It’s set to soar to $120.69 billion by 2029, displaying a compound annual growth rate (CAGR) of 7.4%. The growth surge projected within the forecast period is largely due to rising daily life stress, heightened awareness about health care, increased demand for superior diagnostic instruments, a surge in metabolic conditions detection tests, and growing health insurance coverage. Forefront trends for this forecasted period encompass advancements in medical technology, metabolic health monitoring, implementation of artificial intelligence, incorporation of digital health applications, and the emergence of smart ingestible pills.
Get your metabolic syndrome market report here!
https://www.thebusinessresearchcompany.com/report/metabolic-syndrome-global-market-report
What key factors are fueling the growth of the metabolic syndrome market?
The escalating presence of diseases linked to lifestyle habits is set to propel the metabolic testing market. Lifestyle diseases, or ailments predominantly stemming from unhealthy habits and behaviors rather than genetics or infectious agents, include obesity, cancer, type 2 diabetes, osteoporosis, and mental health issues among others. The mounting instances of these diseases result from sedentary lifestyles, poor dietary habits, increasing stress, and the prevalent consumption of tobacco and alcohol. The role of metabolic syndrome is crucial in accelerating lifestyle diseases by generating a system-wide atmosphere conducive to chronic inflammation, disrupted metabolic operations, and elevated cardiovascular threats. For instance, as per records of the National Health Service England, a UK-based governmental entity, in June 2024, the count of individuals diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023 had escalated by 18% to 3,615,330 from 3,065,825 cases documented in 2022. Hence, the mounting presence of lifestyle diseases will spur the metabolic testing market.
How is the global metabolic syndrome market divided into key segments?
The metabolic syndrome market covered in this report is segmented –
1) By Type: Type 1 Metabolic Syndrome, Type 2 Metabolic Syndrome, Type 3 Metabolic Syndrome
2) By Risk Factors: Obesity, Insulin Resistance, High Blood Pressure, High Cholesterol
3) By Treatment: Medication, Lifestyle Changes, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
5) By End User: Hospitals, Homecare, Specialty Centres, Other End Users
Subsegments:
1) By Type 1 Metabolic Syndrome: Insulin Resistance Syndrome, Abdominal Obesity Syndrome, Hyperglycemia Syndrome
2) By Type 2 Metabolic Syndrome: Elevated Blood Pressure Syndrome, Dyslipidemia Syndrome, Low HDL Cholesterol Syndrome
3) By Type 3 Metabolic Syndrome: Atherosclerotic Cardiovascular Disease Syndrome, Non-Alcoholic Fatty Liver Disease Syndrome, Chronic Inflammation Syndrome
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21218&type=smp
Who are the key firms paving the way for growth in the metabolic syndrome market?
Major companies operating in the metabolic syndrome market are Novo Nordisk A/S, Sanofi S.A., Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck KGaA, Amgen Inc., AstraZeneca PLC, Adocia, Biocon Ltd., Bristol-Myers Squibb Company, Cipla Limited, Herbalife International of America Inc., Abbott Laboratories, Shaklee Corporation, Johnson & Johnson Private Limited, Medtronic plc, Apollo, WW International Inc., Jenny Craig, DSM, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Novartis AG, F. Hoffmann-La Roche AG, Merck & Co. Inc.,
What key trends are currently impacting the metabolic syndrome market’s development?
Key businesses in the metabolic syndrome market are prioritizing the development of cutting-edge remedies, such as medically endorsed probiotic therapies, to improve the condition’s control, treatment, and prevention. A medically endorsed probiotic therapy refers to a probiotic product that has undergone extensive clinical trials to confirm its health advantages and safety for human use. For example, in October 2024, Probi USA, an American company specializing in clinically validated biotics, introduced metabolic health. This breakthrough product contains two probiotic strains, Lactiplantibacillus plantarum 299v (LP299V), and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2). LP299V, substantiated by over 230 publications and eight clinical trials, promotes heart health by enhancing cholesterol levels, reducing inflammation, and boosting blood vessel functionality. L. Paracasei 8700:2, supported by more than 30 publications, contributes to regulating blood pressure, managing cholesterol, and maintaining weight.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21218
What regions are contributing significantly to the growth of the metabolic syndrome market?
North America was the largest region in the metabolic syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolic syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
HyperImmune Globulins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report
Autoimmune Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Smart Insulin Pens Global Market Report 2025
https://thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
